Claims for Patent: 6,599,701

Summary for Patent: 6,599,701

Title:	Identifying organisms by detecting intronic nucleic acids
Abstract:	The present invention provides novel methods for characterizing organisms by identifying the presence, absence, size or sequence polymorphism of intronic regions. The method involves selecting intronic regions from nuclear or organellar gene sequences that are useful for differentiating between and among taxonomic groupings of organisms. Such intronic regions can be analyzed directly or after amplification in a primer extension reaction. The amplification product is then analyzed by, for example, size fractionation, nucleotide sequencing or (RFLP). Intronic regions that contain an open reading frame encoding all or a portion of a protein can be used to generate antibodies to detect the presence or absence of the protein, which indicates the presence or absence of the intronic region. Methods of detecting an organism in a sample by detecting the presence or absence of one or more intronic regions also are provided using nucleic acid based or immunological based approaches. Kits are provided for practicing the methods of the invention.
Inventor(s):	Honeycutt; Rhonda J. (Carlsbad, CA), McClelland; Michael (Encinitas, CA)
Assignee:	Clarity Biosciences, Inc. (San Diego, CA)
Application Number:	09/645,055
Patent Claims:	1. A method of constructing a profile of intronic region characteristics from a given taxonomic group of organisms, said profile being useful for differentiating between or among selected taxonomic groupings of organisms, comprising the steps of: (a) selecting a given taxonomic group of organisms comprising members belonging to smaller taxonomic groups than the given taxonomic group; (b) selecting at least one intronic region known to be found in some or all members of the taxonomic group, wherein said intronic region comprises an organellar intron gene sequence or a nuclear Group I or Group II intron gene sequence; (c) designing a first set of primers that are complementary to a concensus sequence in the intronic region; (d) using the first set of primers to amplify the intronic region from a panel of at least one known member from each of the smaller taxonomic groups thereby forming an amplified nucleic acid product; (e) analyzing the amplified nucleic acid product from step (d) to determine characteristics of the intronic region, wherein said characteristics include the presence or absence of an intron gene sequence, the length of the amplified nucleic acid product, the insertion site of the intron gene sequence, and the sequence of the amplified nucleic acid product; (f) optionally repeating steps (c) and (d) with a second set of primers, at least one of which has increased specificity for some members of the taxonomic group, and analyzing the amplified nucleic acid product obtained therefrom to determine the length of the amplified nucleic acid product; and (g) constructing a profile of the intronic region characteristics, wherein said profile is adapted to differentiate between members of the smaller taxonomic groups within the given taxonomic group. 2. The method of claim 1, wherein the given taxonomic group is a class or subclass of organisms, and wherein the smaller taxonomic groups are genera. 3. The method of claim 1, further comprising the step of hybridizing the amplified products with specific nucleic acid probes. 4. The method of claim 1, wherein the first set of primers flank more than one intron insertion site. 5. The method of claim 1, wherein the first set of primers flank a single intron insertion site. 6. The method of claim 1, wherein the members of the given taxonomic group of organisms are eukaryotes. 7. The method of claim 6, wherein the eukaryotes are fungi. 8. The method of claim 7, wherein the fungi are of the genus Candida or Aspergillus. 9. The method of claim 1, wherein at least one of the primers in the first set of primers is complementary to a sequence of nucleotides in an exon. 10. The method of claim 1, wherein at least one of the primers in the second set of primers is complementary to a sequence of nucleotides in an intron. 11. The method of claim 1, wherein the intronic region further comprises all or a portion of an open reading frame that encodes a protein.

Details for Patent 6,599,701

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2019-08-25
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2019-08-25
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2019-08-25